Ashley Gallagher


FDA approves Dyanavel XR for ADHD treatment in kids 6 and older

November 05, 2021

In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with attention-deficit/hyperactivity disorder (ADHD) by the US Food and Drug Administration (FDA).